(678) 384-7220
info@geovax.com
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers
GeoVax Investor Information
SEC Filings
SEC Filings
Year
2019
Date
02-19
Description
Other Preliminary Proxy Statements
SEC Form
PRE14A
Download Word
Download Excel
Download PDF
GeoVax_PRE_14A_-_2-19-19.pdf
id
About GeoVax
Company
Management
Board of Directors
Scientific Advisory Board
Our Technology
Technology Overview
Publications
Investors
Corporate Profile
News
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Product Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
SUBSCRIBE FOR UPDATES FROM US
Register to receive email alerts for GeoVax press releases
SUBMIT
First Name
Search
About Us
Company
Management
Board of Directors
Scientific Advisory Board
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Immuno-Oncology
Infectious Diseases
Collaborators
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers
